Nuclear interaction model developments in FLUKA

por Fontana, A
Publicado 2015

5th International Workshop on Disordered Systems

por Fontana, A, Viliani, G
Publicado 1994

5th International Workshop on Disordered Systems

por Fontana, A, Viliani, G
Publicado 1995

International Conference on the Young Universe: Galaxy Formation and Evolution at Intermediate and High Redshift

por D'Odorico, S, Fontana, A, Giallongo, E
Publicado 1997

MONET code: evaluation of the dose in Hadrontherapy

por Embriaco, A, Fontana, A, Rotondi, A
Publicado 2019

A model for the accurate computation of the lateral scattering of protons in water

por Bellinzona, EV, Ciocca, M, Embriaco, A, Ferrari, A, Fontana, A, Mairani, A, Parodi, K, Rotondi, A, Sala, P, Tessonnier, T
Publicado 2016

An analytical solution to lateral dose prediction in Hadrontherapy

por Bellinzona, E V, Ciocca, M, Embriaco, A, Ferrari, A, Fontana, A, Mairani, A, Parodi, K, Rotondi, A, Sala, P, Tessonnier, T
Publicado 2015

The ATHENA experiment for the study of antihydrogen

por Amsler, C, Bonomi, G, Fontana, A, Kellerbauer, A, Lagomarsino, V, Lodi Rizzini, E, Rotondi, A, Testera, G, Venturelli, L, Zurlo, N
Publicado 2014

The largest prehistoric mound in Europe is the Bronze-Age Hill of Udine (Italy) and legend linked its origin to Attila the Hun

por Fontana, A., Vinci, G., Ronchi, L., Mocchiutti, A., Muscio, G., Visentini, P., Bassetti, M., Novellino, M. D., Badino, F., Musina, G., Bonomi, S.
Publicado 2023

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

por Bengala, C, Bettelli, S, Bertolini, F, Sartori, G, Fontana, A, Malavasi, N, Depenni, R, Zironi, S, Del Giovane, C, Luppi, G, Conte, P F
Publicado 2010

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

por Galli, L, Fontana, A, Galli, C, Landi, L, Fontana, E, Antonuzzo, A, Andreuccetti, M, Aitini, E, Barbieri, R, Di Marsico, R, Falcone, A
Publicado 2007

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes

por Cavelti-Weder, Claudia, Furrer, Romana, Keller, Cornelia, Babians-Brunner, Andrea, Solinger, Alan M., Gast, H., Fontana, A., Donath, Marc Y., Penner, Iris K.
Publicado 2011

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

por Bengala, C, Bertolini, F, Malavasi, N, Boni, C, Aitini, E, Dealis, C, Zironi, S, Depenni, R, Fontana, A, Del Giovane, C, Luppi, G, Conte, P
Publicado 2010

Cyclotron-based production of the theranostic radionuclides $^{67}$Cu and $^{47}$Sc

por Pupillo, G, Mou, L, Martini, P, Pasquali, M, Esposito, J, Duatti, A, Rossi Alvarez, C, Skliarova, H, Cisternino, S, Boschi, A, Canton, L, Fontana, A, Haddad, F
Publicado 2019

Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case–control study

por Vineis, P, Miligi, L, Crosignani, P, Davico, L, Fontana, A, Masala, G, Nanni, O, Ramazzotti, V, Rodella, S, Stagnaro, E, Tumino, R, Viganò, C, Vindigni, C, Costantini, A S
Publicado 2003

VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide

por Orlandi, P, Fontana, A, Fioravanti, A, Di Desidero, T, Galli, L, Derosa, L, Canu, B, Marconcini, R, Biasco, E, Solini, A, Francia, G, Danesi, R, Falcone, A, Bocci, G
Publicado 2013

Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

por Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Lorenzini, G., Isca, C., Fontana, A., Livi, L., Piacentini, F., Fogli, S., De Giorgi, U., Danesi, R.
Publicado 2021

Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

por Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Lorenzini, G., Isca, C., Fontana, A., Livi, L., Piacentini, F., Fogli, S., De Giorgi, U., Danesi, R.
Publicado 2022

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

por Bengala, C, Guarneri, V, Giovannetti, E, Lencioni, M, Fontana, E, Mey, V, Fontana, A, Boggi, U, Del Chiaro, M, Danesi, R, Ricci, S, Mosca, F, Del Tacca, M, Conte, P F
Publicado 2005

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

por Bertolini, F, Malavasi, N, Scarabelli, L, Fiocchi, F, Bagni, B, Giovane, C Del, Colucci, G, Gerunda, G E, Depenni, R, Zironi, S, Fontana, A, Pettorelli, E, Luppi, G, Conte, P F
Publicado 2011